Immunomic Therapeutics, Inc. Press Releases - EIN Presswire

Published on April 24, 2013 - 21:22 GMT

Immunomic Therapeutics Announces Interim Data Analysis of Phase I Study to Treat Japanese Red Cedar Allergy

/EINPresswire.com/ FOR IMMEDIATE RELEASE Hershey, PA, & Rockville, MD April 11th, 2013 – Immunomic Therapeutics, Inc., (“ITI,” Hershey, PA), a leading developer of novel allergy immunotherapies, announced the preliminary results of a Phase I Study to …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on April 16, 2013 - 03:15 GMT

Immunomic Therapeutics, Inc., Announces Bernard C. Rudnick’s Nomination to the Board of Directors

/EINPresswire.com/ FOR IMMEDIATE RELEASE Hershey, PA, & Rockville, MD April 10th, 2013 – Immunomic Therapeutics, Inc., (“ITI,” Hershey, PA), a leader in developing novel allergy immunotherapies, announced today the nomination of Bernard C. Rudnick to …

Distribution channels: Business & Economy

Published on March 28, 2013 - 20:25 GMT

Immunomic Therapeutics Has Generated More Than $6.5 Million in Funding To Date

/EINPresswire.com/ FOR IMMEDIATE RELEASE Hershey, PA, & Rockville, MD March 25th, 2013 – Immunomic Therapeutics, Inc., (“ITI,”Hershey, PA) a leader in developing novel allergy immunotherapies, announced today that is has raised more than $6.5 million …

Distribution channels: Banking, Finance & Investment Industry

Published on February 26, 2013 - 07:32 GMT

COUNCIL FOR BILE ACID DEFICIENCY DISEASES JOINS NORD AND AHRQ

/EINPresswire.com/ FOR IMMEDIATE RELEASE February 12, 2013 TO: BILE ACID DEFICIENCY DISEASES: PATIENTS AND FAMILIES On January 25th, the Council For Bile Acid Deficiency Diseases (The Council) sponsored the participation of a North Carolina …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on February 22, 2013 - 20:19 GMT

Immunomic Therapeutics Receives Notice of Issuance for Chimeric Vaccines Patent

/EINPresswire.com/ FOR IMMEDIATE RELEASE Hershey, PA, February 22nd, 2013 – Immunomic Therapeutics, Inc., (“ITI”) a privately-held biotechnology company announced that the U.S. Patent and Trademark Office issued US Patent No. 8,318,173, for the …

Distribution channels: Healthcare & Pharmaceuticals Industry

Published on January 24, 2013 - 23:18 GMT

Immunomic Therapeutics Completes Enrollment for Phase I of JRC-LAMP-Vax Vaccine to Treat Japanese Red Cedar Allergy

/EINPresswire.com/ FOR IMMEDIATE RELEASE Hershey, PA, & Rockville, MD January 24th, 2013 – Immunomic Therapeutics, Inc., (“ITI,” Hershey, PA) a privately-held biotechnology company developing novel allergy immunotherapies, announced today that is has …

Distribution channels: Technology